FDA.reportPublic FDA data

Onfi 2.5 MG per 1 ML Oral Suspension

RxCUI
1366196
RxNorm name
Onfi 2.5 MG per 1 ML Oral Suspension
Display name
Onfi 2.5 MG per 1 ML Oral Suspension
Full name
Onfi 2.5 MG per 1 ML Oral Suspension
Term type
SY
Status
DailyMed mapping
Updated
2026-06-04 23:39:24

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 1 matching rows.

Set ID, RxNorm mappings, Terms table
Set IDRxNorm mappingsTermsSPL versionLabelEffective
de03bd69-2dca-459c-93b4-541fd3e9571cOnfi 2.5 MG in 1 mL Oral Suspension [PSN] · clobazam 2.5 MG/ML Oral Suspension [Onfi] [SBD] · Onfi 2.5 MG per 1 ML Oral Suspension [SY] · Onfi 2.5 MG/ML Oral Suspension [SY]442These highlights do not include all the information needed to use ONFI safely and effectively. See full prescribing information for ONFI. ONFI ® (clobazam) tablets, for oral use, CIV ONFI ® (clobazam) oral suspension, CIV Initial U.S. Approval: 201120240312